Global Human Vaccine Market 2018-2022: Emergence of New Technologies for Delivery of Vaccines

News provided by

Oct 26, 2018, 07:30 ET

DUBLIN, Oct. 26, 2018 /PRNewswire/ --

The "Global Human Vaccine Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Human Vaccine Market to grow at a CAGR of 7.73% during the period 2018-2022.

Global Human Vaccines Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also includes a discussion of the Key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the retail sales of human vaccines across the globe. Vaccines have been impacting the global health scenario by reducing disease incidence, mortality rates, and life expectancy.

According to the report, one driver influencing this market is the increase in investments in vaccine segment. High investments by vaccine manufacturers are necessary to develop a wide variety of vaccines, reduce product and process complexity, and maintain aggressive timelines for vaccine development and life cycle management.

One trend affecting this market is the varied demand for vaccines in high-income and developing countries. The demand for novel vaccines is high in developing economies as they receive financial support.

Further, the report states that one challenge affecting this market is the rising pricing pressure. Leading companies have been under pressure from medical associations to lower the price of vaccines so that governments can procure them for public immunization programs.

Key questions answered in this report

What will the market size be in 2022 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Key Market Trends

Varied demand for vaccines in high-income and developing countries
Increase in strategic alliances and M&A
Public-private partnership models and technology transfer to local players
Innovative partnerships improving global vaccine access
Emergence of new technologies for delivery of vaccines
Differential pricing to accelerate uptake in low-income countries

Key vendors

GlaxoSmithKline
Merck
Pfizer
Sanofi

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

Market ecosystem
Market characteristics
Market segmentation analysis

PART 05: PIPELINE ANALYSIS

PART 06: MARKET SIZING

Market definition
Market sizing 2017
Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

PART 08: MARKET SEGMENTATION BY ROA

Segmentation by ROA
Comparison by ROA
Oral - Market size and forecast 2017-2022
Intramuscular - Market size and forecast 2017-2022
Intradermal - Market size and forecast 2017-2022
Subcutaneous - Market size and forecast 2017-2022
Intranasal - Market size and forecast 2017-2022
Market opportunity by ROA

PART 09: MARKET SEGMENTATION BY VACCINE TYPE

Market segmentation by vaccine type

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

Geographical segmentation
Regional comparison
Americas - Market size and forecast 2017-2022
EMEA - Market size and forecast 2017-2022
APAC - Market size and forecast 2017-2022
Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

Market drivers
Market challenges

PART 14: MARKET TRENDS

Varied demand for vaccines in high-income and developing countries
Increase in strategic alliances and M&A
Public-private partnership models and technology transfer to local players
Innovative partnerships improving global vaccine access
Emergence of new technologies for delivery of vaccines
Differential pricing to accelerate uptake in low-income countries

PART 15: VENDOR LANDSCAPE

Overview
Landscape disruption

PART 16: VENDOR ANALYSIS

Vendors covered
Vendor classification
Market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/research/c9wk54/global_human?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets